STOCK TITAN

Guardant Health (GH) CCO receives 7,414 shares from RSU vesting and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Commercial Officer Chris Freeman reported compensation-related equity activity involving restricted stock units. On July 1, 2026, RSU awards vested and were converted into a total of 7,414 shares of common stock, reflecting derivative exercises rather than open-market purchases.

To cover tax obligations arising from this vesting, 3,141 shares of common stock were retained by the company at a value of $170.77 per share, as noted in the footnotes. The transactions do not include any open-market buying or selling, and are characterized as routine equity compensation and tax withholding events.

Positive

  • None.

Negative

  • None.
Insider Freeman Chris
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 1,928 $0.00 --
Exercise Restricted Stock Units 1,667 $0.00 --
Exercise Restricted Stock Units 2,526 $0.00 --
Exercise Restricted Stock Units 1,293 $0.00 --
Exercise Common Stock 1,928 $0.00 --
Exercise Common Stock 1,667 $0.00 --
Exercise Common Stock 2,526 $0.00 --
Exercise Common Stock 1,293 $0.00 --
Tax Withholding Common Stock 3,141 $170.77 $536K
Holdings After Transaction: Restricted Stock Units — 1,929 shares (Direct, null); Common Stock — 63,029 shares (Direct, null)
Footnotes (1)
  1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
RSU shares vested 7,414 shares Common stock from restricted stock unit vesting on July 1, 2026
Shares withheld for taxes 3,141 shares Common stock retained by company to satisfy tax withholding
Tax withholding share value $170.77 per share Value used for 3,141 shares withheld for tax obligations
Derivative exercises 4 transactions Exercise or conversion of derivative securities (RSUs) with code M
Shares from derivative exercises 7,414 shares ExerciseShares reported in transaction summary
Tax-withholding disposition 1 transaction Code F entry retaining shares to cover tax liability
Restricted Stock Units financial
"This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
restricted stock unit award financial
"This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Freeman Chris

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026M1,928A$063,029D
Common Stock07/01/2026M1,667A$064,696D
Common Stock07/01/2026M2,526A$067,222D
Common Stock07/01/2026M1,293A$068,515D
Common Stock07/01/2026F3,141(1)D$170.7765,374D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$007/01/2026M1,928 (2) (3)Common Stock1,928$01,929D
Restricted Stock Units$007/01/2026M1,667 (4) (3)Common Stock1,667$01,668D
Restricted Stock Units$007/01/2026M2,526 (5) (3)Common Stock2,526$012,632D
Restricted Stock Units$007/01/2026M1,293 (6) (3)Common Stock1,293$09,046D
Explanation of Responses:
1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
3. Not applicable for Restricted Stock Units.
4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Chris Freeman07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Guardant Health (GH) report for Chris Freeman?

Guardant Health reported that Chief Commercial Officer Chris Freeman had restricted stock units vest into 7,414 common shares, with 3,141 shares withheld by the company to cover taxes. These are equity compensation and tax-withholding events, not open-market trades.

Did Guardant Health’s Chris Freeman buy or sell GH shares on the market?

The filing shows no open-market buying or selling by Chris Freeman. Shares were issued through RSU vesting and some were retained by the company to satisfy tax withholding, which is a standard, non-market equity compensation mechanism.

How many Guardant Health shares came from Chris Freeman’s RSU vesting?

Vesting of multiple restricted stock unit awards delivered 7,414 shares of Guardant Health common stock to Chris Freeman. These shares resulted from derivative exercises reported under transaction code M, meaning they came from equity awards rather than market purchases.

How many Guardant Health shares were withheld for Chris Freeman’s taxes?

The company retained 3,141 shares of Guardant Health common stock to meet Chris Freeman’s tax withholding obligations. Footnotes specify this amount did not exceed the related tax liability, and the withholding price used was $170.77 per share.

What do the F and M transaction codes mean in Chris Freeman’s Guardant Health filing?

In this filing, code F reflects shares withheld to pay tax obligations, while code M indicates exercises or conversions of derivative securities, here restricted stock units. Together they describe RSU vesting and associated tax withholding, not discretionary stock trades.

Are Chris Freeman’s Guardant Health RSUs subject to time-based vesting schedules?

Yes. Footnotes explain multiple RSU grants vest over three- or four-year periods, with initial portions vesting on specific October or April dates and remaining shares vesting in equal quarterly installments, reflecting typical time-based executive equity compensation structures.